AI Applications for Drug Discovery and Development: Innovator Meets Regulator – the Challenge for AI in Biotech
Gail Javitt, Robert Wanerman, and Alaap Shah, Members of the Firm, will present "Innovator Meets Regulator: The Challenge for AI in Biotech" at the AI Applications for Drug Discovery and Development conference. The session will discuss how AI, machine learning, and other algorithm solutions have great promise but also pose significant legal, regulatory, and ethical risks. Whether you are an AI developer, consumer, or third-party beneficiary, the success of creating and using AI solutions throughout their life cycle will depend on effectively understanding and navigating those risks.
For more information, please visit here.